Abstract
Purpose
Both γ-aminobutyric acid (GABA)A receptors and nicotinic cholinergic receptors have important roles in antinociception in the spinal cord. The antinociceptive effects of midazolam (a GABAA agonist) and epibatidine (a nicotinic cholinergic agonist) in the spinal cord have been reported. The present study was performed to investigate the interaction between intrathecal midazolam and epibatidine.
Methods
Sprague-Dawley rats with lumbar intrathecal catheters were tested for their tail withdrawal response to thermal stimulation (tail-flick test) or for their paw flinches in response to formalin injection (formalin test) after the intrathecal administration of epibatidine or a combination of midazolam and epibatidine. The combination doses were 1/16, 1/8, 1/4, 1/2, 1, 2, and 4 times the 50% effective dose (ED50) of each agent in each test. The interaction of midazolam and epibatidine was investigated by isobolographic analysis. Behavioral side effects were also investigated.
Results
In the tail-flick test, the ED50 values of the combination were significantly higher than the theoretical additive values. In the formalin test, the ED50 values of the combination were significantly lower than the theoretical additive values in phase 1, but were not different from the theoretical additive values in phase 2.
Conclusion
The intrathecal combination of midazolam and epibatidine had antagonistic effects on thermal acute nociception, while the combination had synergistic effects on acute inflammatory nociception, with only additive effects on inflammatory-facilitated nociceptive responses.
Similar content being viewed by others
References
Edwards M, Serrao JM, Gent JP, Goodchild CS. On the mechanism by which midazolam causes spinally mediated analgesia. Anesthesiology. 1990;73:273–277.
Nishiyama T. Analgesic effects of systemic midazolam: comparison with intrathecal administration. Can J Anaesth. 2006;53:1004–1009.
Serrao JM, Marks RL, Morley SJ, Goodchild CS. Intrathecal midazolam for the treatment of chronic mechanical low back pain: a controlled comparison with epidural steroid in a pilot study. Pain. 1992;48:5–12.
Nishiyama T, Yokoyama T, Hanaoka K. Midazolam improves postoperative epidural analgesia with continuous infusion of local anaesthetics. Can J Anaesth. 1998;45:551–555.
Molinero MT, Del Rio J. Substance P, nicotinic acetylcholine receptors and antinociception in the rat. Neuropharmacology. 1987;26:1715–1720.
Lawand NB, Lu Y, Westlund KN. Nicotinic cholinergic receptors: potential targets for inflammatory pain relief. Pain. 1990;80:291–299.
Phan DV, Doda M, Bite A, Gyorgy I. Antinociceptive activity of nicotine. Acta Physiol Acad Sci Hung. 1973;1:85–93.
Sullivan JP, Bannon AW. Epibatidine: pharmacological properties of a novel nicotinic acetylcholine receptor agonist and analgesic agent. CNS Drugs. 1996;2:21–39.
Nishiyama T, Gyermek L, Trudell ML, Hanaoka K. Spinally mediated analgesia and receptor binding affinity of epibatidine analogs. Eur J Pharmacol. 2003;470:27–31.
Bonhaus AW, Bley KR, Broka CA, Fontana DJ, Leung E, Lewis R, Shieh A, Wong EH. Characterization of the electrophysiological, biochemical and behavioral actions of epibatidine. J Pharmacol Exp Ther. 1995;272:1199–1203.
Tallarida RJ, Porreca F, Cowan A. Statistical analysis of drug—drug and site-site interactions with isobologram. Life Sci. 1989;46:947–961.
Kohno T, Wakai A, Ataka T, Ikoma M, Yamakura T, Baba H. Actions of midazolam on excitatory transmission in dorsal horn neurons of adult rat spinal cord. Anesthesiology. 2006;104:338–343.
Rudomin P. Primary afferent depolarization produced in A delta and C fibres by glutamate spillover? New ways to look at old things. J Physiol. 2000;528:1.
Clavier N, Lombard MC, Besson JM. Benzodiazepines and pain: effects of midazolam on the activities of nociceptive non-specific dorsal horn neurons in the rat spinal cord. Pain. 1992;48:61–71.
Rogers DT, Iwamoto ET. Multiple spinal mediators in parenteral nicotine-induced antinociception. J Pharmacol Exp Ther. 1993;267:341–349.
Gillberg PG, d’Argy R, Aquilonius SM. Autoradiographic distribution of [3H] acetylcholine binding sites in the cervical spinal cord of man and some other species. Neurosci Lett. 1988;90:197–202.
Laing I, Todd AJ, Heizmann CW, Schmidt HH. Subpopulations of GABAergic neurons in laminae I–III of rat spinal dorsal horn defined by coexistence with classical transmitters, peptides, nitric oxide synthase or parvalbumin. Neuroscience. 1994;61:159–166.
Todd AJ. Immunohistochemical evidence that acetylcholine and glycine exist in different populations of GABAergic neurons in lamina III of rat spinal dorsal horn. Neuroscience. 1991;44:741–746.
Curzon P, Nikkel AL, Bannon AW, Arneric SP, Decker MW. Differences between the antinociceptive effects of the cholinergic channel activators A-85380 and (±)-epibatidine in rats. J Pharmacol Exp Ther. 1998;287:847–853.
Flores CM, Wilson SG, Mogil JM. Pharmacogenetic variability in neuronal nicotinic receptor-mediated antinociception. Pharmacogenetics. 1999;9:619–625.
Badio B, Daly JW. Epibatidine, a potent analgesic and nicotinic agonist. Mol Pharmacol. 1994;45:563–569.
Rao TS, Correa LD, Reid RT, Lloyd GK. Evaluation of antinociceptive effects of neuronal nicotinic acetylcholine receptor (nAChR) ligands in the rat tail-flick assay. Neuropharmacology. 1996;35:393–405.
Rupniak NMJ, Patel S, Marwood R, Webb J, Traynor JR, Elliott J, Freedman SB, Fletcher SR, Hill RG. Antinociceptive and toxic effects of (+)-epibatidine oxalate attributable to nicotinic agonist activity. Br J Pharmacol. 1994;113:1487–1493.
Sullivan JP, Decker MW, Brioni JD, Donnelly-Roberts D, Anderson DJ, Kang CH, Adams P, Piattoni-Kaplan M, Buckley MJ. (±)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors. J Pharmacol Exp Ther. 1994;271:624–631.
Advokat C, Rutherford D. Selective antinociceptive effect of excitatory amino acid antagonists in intact and acute spinal rats. Pharmacol Biochem Behav. 1995;51:855–860.
Khan IM, Yaksh TL, Taylor P. Epibatidine binding sites and activity in the spinal cord. Brain Res. 1997;753:269–282.
Puig S, Sorkin LS. Formalin-evoked activity in identified primary afferent fibres: systemic lidocaine suppresses phase 2 activity. Pain. 1996;64:345–357.
Li J, Simone DA, Larson A. Windup leads to characteristics of central sensitization. Pain. 1999;79:75–82.
Author information
Authors and Affiliations
Additional information
This work was done at the Department of Anesthesiology, The University of Tokyo.
About this article
Cite this article
Nishiyama, T. Interaction between midazolam and epibatidine in spinally mediated antinociception in rats. J Anesth 23, 370–377 (2009). https://doi.org/10.1007/s00540-009-0765-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-009-0765-0